Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Cash & Current Investments (2016 - 2025)

Healthstream (HSTM) has disclosed Cash & Current Investments for 16 consecutive years, with $57.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Current Investments fell 41.36% to $57.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $57.0 million, a 41.36% decrease, with the full-year FY2025 number at $57.0 million, down 41.36% from a year prior.
  • Cash & Current Investments was $57.0 million for Q4 2025 at Healthstream, down from $92.6 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $113.3 million in Q1 2025 to a low of $39.2 million in Q2 2022.
  • A 5-year average of $69.2 million and a median of $59.6 million in 2021 define the central range for Cash & Current Investments.
  • Peak YoY movement for Cash & Current Investments: plummeted 60.59% in 2021, then surged 48.31% in 2024.
  • Healthstream's Cash & Current Investments stood at $51.9 million in 2021, then increased by 3.78% to $53.9 million in 2022, then skyrocketed by 31.95% to $71.1 million in 2023, then skyrocketed by 36.67% to $97.2 million in 2024, then tumbled by 41.36% to $57.0 million in 2025.
  • Per Business Quant, the three most recent readings for HSTM's Cash & Current Investments are $57.0 million (Q4 2025), $92.6 million (Q3 2025), and $90.6 million (Q2 2025).